City of Broken Arrow v. Purdue Pharma L.P. et al
City of Broken Arrow |
Insys Therapeutic, Inc., Anda, Inc., Purdue Pharma L.P., Mallinckrodt LLC, Anda Pharmaceuticals, Inc., Morris & Dickson Co, LLC, Mallinckrodt PLC, Perry Fine, Teva Pharmaceutical Industries, Ltd., Actavis PLC, TEVA Pharmaceuticals USA, Inc., Keysource Medical, Inc., Endo Pharmaceuticals Inc., Actavis LLC, Allergan PLC, Cardinal Health, Inc., Joshua Livingston, Quest Pharmaceuticals, Inc., Cephalon Inc., Actavis Pharma, Inc., Watson Laboratories, Inc., AmerisourceBergen Corp., Harvard Drug Group, LLC, The, Endo Health Solutions Inc., Johnson & Johnson, Watson Pharmaceuticals, Inc., Russel Portenoy, Purdue Pharma Inc., McKesson Corp., Lynn Webster, Watson Pharma, Inc., Physicians Total Care, Inc., GCP Pharma, LLC, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc., Purdue Frederick Company, Inc., The and Janssen Pharmaceuticals, Inc. |
4:2019cv00047 |
January 29, 2019 |
US District Court for the Northern District of Oklahoma |
Jodi F Jayne |
Terence Kern |
P.I.: Other |
28 U.S.C. § 1332 |
Both |
Docket Report
This docket was last retrieved on March 29, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 69 Joint BRIEF in Support of Motion (Re: #55 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation ) by AmerisourceBergen Corp., Cardinal Health, Inc., McKesson Corp. ; (Campbell, Stuart) |
Filing 68 REPLY to Response to Motion (Re: #51 MOTION to Remand ) by City of Broken Arrow ; (Court, Todd) |
Filing 67 RESPONSE in Opposition to Motion (Re: #55 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation ) by City of Broken Arrow ; (With attachments) (Court, Todd) |
Filing 66 RESPONSE in Opposition to Motion (Re: #51 MOTION to Remand ) by McKesson Corp. ; (With attachments) (Campbell, Stuart) |
Filing 65 RESPONSE in Opposition to Motion (Re: #51 MOTION to Remand ) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. ; (Zschiesche, Raymond) |
Filing 64 MINUTE ORDER by Court Clerk , directing Harvard Drug Group, LLC, The to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) |
Filing 63 Amended CORPORATE DISCLOSURE STATEMENT (identifying: Other Affiliate Walgreens Boots Alliance Holdings LLC for AmerisourceBergen Corp.) by AmerisourceBergen Corp. (Huntsman, Susan) |
Filing 62 ORDER by Judge Terence Kern ; granting #61 Motion for Extension of Time to Answer (Re: State Court Petition/Complaint ) (pll, Dpty Clk) |
Filing 61 Unopposed MOTION for Extension of Time to Answer or File Responsive Pleading (Re: State Court Petition/Complaint ) by Harvard Drug Group, LLC, The (Ray, Ryan) |
Filing 60 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Cardinal Health, Inc., Corporate Parent Generic Drug Holdings, Inc., Corporate Parent HDG Acquisition, Inc., Corporate Parent Cardinal Health 110, LLC for Harvard Drug Group, LLC, The) by Harvard Drug Group, LLC, The (Ray, Ryan) |
Filing 59 ATTORNEY APPEARANCE by Ryan A Ray on behalf of Harvard Drug Group, LLC, The [Note: Attorney Ryan A Ray added to party Harvard Drug Group, LLC, The(pty:dft).] (Ray, Ryan) |
Filing 58 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Anda, Inc.) by Anda, Inc. (Curran, Jeffrey) |
Filing 57 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Anda Pharmaceuticals, Inc.) by Anda Pharmaceuticals, Inc. (Curran, Jeffrey) |
Filing 56 MINUTE ORDER by Judge Terence Kern - Defendants' Motion for Reconsideration of Order Granting Plaintiff's Motion for Expedited Briefing (Doc. 54) is hereby granted. Plaintiffs' Motion for Expedited Briefing (Doc. 52) is denied. Defendants' Response to Plaintiff's Motion to Remand (Doc. 51) shall be filed on or before March 14, 2019. Plaintiff may file an expedited Reply if it desires. ; setting/resetting deadline(s)/hearing(s): ( Responses due by 3/14/2019, Replies due by 3/28/2019); granting #54 Motion to Reconsider (Re: #51 MOTION to Remand , #52 MOTION to Accelerate/Extend/Reset Hearing(s)/Deadline(s) (MOTION FOR EXPEDITED BRIEFING) ) (This entry is the Official Order of the Court. No document is attached.) (lmc, Chambers) |
Filing 55 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation by AmerisourceBergen Corp., Cardinal Health, Inc., McKesson Corp. (With attachments) (Campbell, Stuart) |
Filing 54 MOTION to Reconsider Order Granting Plaintiff's Motion for Expedited Briefing (Re: #53 Order,, Setting/Resetting Deadline(s)/Hearing(s),, Ruling on Motion to Accelerate/Extend/Reset Hearing(s)/Deadline(s), ) by AmerisourceBergen Corp., Cardinal Health, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals Inc., McKesson Corp. (Campbell, Stuart) |
Filing 53 ORDER by Judge Terence Kern ; setting/resetting deadline(s)/hearing(s): ( Responses due by 2/28/2019, Replies due by 3/4/2019); granting #52 Motion to Accelerate/Extend/Reset Hearing(s)/Deadline(s) (Re: #51 MOTION to Remand ) (lmc, Chambers) |
Filing 52 MOTION to Accelerate/Extend/Reset Hearing(s)/Deadline(s) (MOTION FOR EXPEDITED BRIEFING) (Re: #51 MOTION to Remand ) by City of Broken Arrow (Court, Todd) |
Filing 51 MOTION to Remand by City of Broken Arrow (With attachments) (Court, Todd) |
Filing 50 ATTORNEY APPEARANCE by Jeffrey Allen Curran on behalf of Anda Pharmaceuticals, Inc., Anda, Inc. [Note: Attorney Jeffrey Allen Curran added to party Anda Pharmaceuticals, Inc.(pty:dft), Attorney Jeffrey Allen Curran added to party Anda, Inc.(pty:dft).] (Curran, Jeffrey) |
Filing 49 ORDER by Judge Terence Kern - Tiffany M. Ikeda and John D. Lombardo are admitted Pro Hac Vice for Defendants Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. ; ; granting #47 Motion for Admission Pro Hac Vice; granting #48 Motion for Admission Pro Hac Vice (lmc, Chambers) |
Filing 48 MOTION for Attorney(s) John D. Lombardo to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2018989) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (With attachments) (Zschiesche, Raymond) |
Filing 47 MOTION for Attorney(s) Tiffany M. Ikeda to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2018986) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (With attachments) (Zschiesche, Raymond) |
Filing 46 MINUTE ORDER by Court Clerk , directing Anda Pharmaceuticals, Inc. and Anda, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) |
Filing 45 ORDER by Judge Terence Kern regarding Anda Defendants response to Petition. ; granting #44 Motion for Extension of Time to Answer (lmc, Chambers) |
Filing 44 Unopposed MOTION for Extension of Time to Answer Move, or Otherwise Respond (Re: State Court Petition/Complaint ) by Anda Pharmaceuticals, Inc., Anda, Inc. (Hemphill, Lisa) |
Filing 43 ATTORNEY APPEARANCE by Lisa Renee Hemphill on behalf of Anda Pharmaceuticals, Inc., Anda, Inc. [Note: Attorney Lisa Renee Hemphill added to party Anda Pharmaceuticals, Inc.(pty:dft), Attorney Lisa Renee Hemphill added to party Anda, Inc.(pty:dft).] (Hemphill, Lisa) |
Filing 42 MINUTE ORDER by Court Clerk , directing Cephalon Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Actavis Pharma, Inc., Actavis LLC to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) |
NOTICE of Docket Entry Modification; Error: filer selected in error (Watson Pharma, Inc.); Correction: removed filer selected in error (Re: #40 Appearance - Attorney, ) (srt, Dpty Clk) |
NOTICE of Docket Entry Modification; Error: wrong filer selected; Correction: removed filer selected in error (Watson Pharma, Inc.) and added correct filer (Watson Laboratories, Inc.) (Re: #39 Appearance - Attorney,, ) (srt, Dpty Clk) |
Filing 41 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Actavis LLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.) by Actavis LLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (Merkley, Nicholas) |
Filing 40 ATTORNEY APPEARANCE by Nicholas Vernon Merkley on behalf of Actavis LLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., [Note: Attorney Nicholas Vernon Merkley added to party Watson Pharma, Inc.(pty:dft).] (Merkley, Nicholas) Modified on 2/13/2019 to remove filer selected in error (Watson Pharma, Inc.) (srt, Dpty Clk). |
Filing 39 ATTORNEY APPEARANCE by Ashley E Quinn on behalf of Actavis LLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceuticals USA, Inc., Watson Pharma, Inc. [Note: Attorney Ashley E Quinn added to party Actavis LLC(pty:dft), Attorney Ashley E Quinn added to party Actavis Pharma, Inc.(pty:dft), Attorney Ashley E Quinn added to party Cephalon Inc.(pty:dft), Attorney Ashley E Quinn added to party Teva Pharmaceuticals USA, Inc.(pty:dft), Attorney Ashley E Quinn added to party Watson Laboratories, Inc. (pty:dft).] (Quinn, Ashley) Modified on 2/13/2019 - removed filer selected in error (Watson Pharma, Inc.) and added correct filer (Watson Laboratories, Inc.) (srt, Dpty Clk). |
Filing 38 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Pharmaceutical Research Associates, Inc. for Purdue Frederick Company, Inc., The) by Purdue Frederick Company, Inc., The (Lamirand, Jennifer) |
Filing 37 CORPORATE DISCLOSURE STATEMENT by Purdue Pharma Inc. (Lamirand, Jennifer) |
Filing 36 CORPORATE DISCLOSURE STATEMENT by Purdue Pharma L.P. (Lamirand, Jennifer) |
Filing 35 MINUTE ORDER by Court Clerk , directing Quest Pharmaceuticals, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) |
Filing 34 ERRATA/CORRECTION (Re: #30 Notice (Other) ) by McKesson Corp. (With attachments) (Campbell, Stuart) |
Filing 33 MINUTE ORDER by Judge Terence Kern - Defendant Quest Pharmaceuticals, Inc.'s Unopposed Motion to Extend Time to Answer, Move or Otherwise Respond to Petition Under Rule 12 (Doc. 32) is hereby granted. The time for Defendant to answer, move or otherwise respond to the Petition is hereby extended until 45 days following (1) a decision by the Judicial Panel on Multidistrict Litigation granting a motion to vacate a conditional transfer order covering this action or otherwise finally denying transfer of this action or (2) this Court's ruling on any motion to remand, whichever is later. ; granting #32 Motion for Extension of Time to Answer (This entry is the Official Order of the Court. No document is attached.) (lmc, Chambers) |
Filing 32 MOTION for Extension of Time to Answer , Move, or Otherwise Respond to Petition under Rule 12 (Re: State Court Petition/Complaint ) by Quest Pharmaceuticals, Inc. (Riddles, D) |
Filing 31 MINUTE ORDER by Court Clerk , directing Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. [ to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (sc, Dpty Clk) |
NOTICE of Docket Entry Modification; Error: wrong event selected (Notice - Other); Correction: changed text to reflect correct event (Amended NOTICE of Removal) (Re: #30 Notice (Other) ) (sac-qc, Dpty Clk) |
Filing 30 Amended NOTICE of Removal (Re: #2 NOTICE of Removal) by McKesson Corp. (With attachments) (Campbell, Stuart) Modified on 2/8/2019 to change text to reflect correct event and add link (sac-qc, Dpty Clk). |
Filing 29 CORPORATE DISCLOSURE STATEMENT by Quest Pharmaceuticals, Inc. (Riddles, D) |
Filing 28 ATTORNEY APPEARANCE by D Todd Riddles on behalf of Quest Pharmaceuticals, Inc. [Note: Attorney D Todd Riddles added to party Quest Pharmaceuticals, Inc.(pty:dft).] (Riddles, D) |
Filing 27 MINUTE ORDER by Court Clerk , directing Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (sc, Dpty Clk) |
Filing 26 ATTORNEY APPEARANCE by Jennifer Nicole Lamirand on behalf of Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. [Note: Attorney Jennifer Nicole Lamirand added to party Purdue Frederick Company, Inc., The(pty:dft), Attorney Jennifer Nicole Lamirand added to party Purdue Pharma Inc.(pty:dft), Attorney Jennifer Nicole Lamirand added to party Purdue Pharma L.P.(pty:dft).] (Lamirand, Jennifer) |
Filing 25 ATTORNEY APPEARANCE by Sanford C Coats on behalf of Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. (Coats, Sanford) |
Filing 24 ORDER by Judge Terence Kern - Manufacturer Defendants' answer or responsive pleading due 45 days after ruling on any motion to remand or transfer case to MDL Panel. ; granting #23 Motion for Extension of Time to Answer (lmc, Chambers) |
Filing 23 Unopposed MOTION for Extension of Time to Answer (Re: State Court Petition/Complaint ) by Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) |
Filing 22 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Janssen Pharmaceuticals, Inc. for Janssen Pharmaceutica, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc.) by Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) |
Filing 21 ATTORNEY APPEARANCE by Michael W Ridgeway on behalf of Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) |
Filing 20 ATTORNEY APPEARANCE by John Hunt Sparks on behalf of Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Sparks, John) |
Filing 19 ORDER by Judge Terence Kern - Defendants McKesson, Cardinal Health, Inc., and AmerisourceBergen Drug Corporation's answer or responsive pleading due 45 days after ruling on any motion to remand or transfer case to MDL Panel. ; granting #18 Motion for Extension of Time to Answer (lmc, Chambers) |
Filing 18 Unopposed MOTION for Extension of Time to Answer (Re: State Court Petition/Complaint ) by AmerisourceBergen Corp., Cardinal Health, Inc., McKesson Corp. (Campbell, Stuart) |
Filing 17 ATTORNEY APPEARANCE by Kaylee Patricia Davis-Maddy on behalf of McKesson Corp. (Davis-Maddy, Kaylee) |
Filing 16 STATUS REPORT on Removed Action by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) |
Filing 15 MINUTE ORDER by Court Clerk , directing John Lombardo and Tiffany Ikeda to file by 2/21/2019 a Motion for Admission Pro Hac Vice per Local Civil Rule 83.2. Additionally, if you intend to practice in this district in the future and want to become a member of this district, please submit an application for attorney admission. (This entry is the Official Order of the Court. No document is attached.) (eaw, Dpty Clk) |
Filing 14 CORPORATE DISCLOSURE STATEMENT by McKesson Corp. (Campbell, Stuart) |
Filing 13 ATTORNEY APPEARANCE by Stuart Douglas Campbell on behalf of McKesson Corp. (Campbell, Stuart) |
Filing 12 CORPORATE DISCLOSURE STATEMENT by Cardinal Health, Inc. (Ray, Ryan) |
Filing 11 ATTORNEY APPEARANCE by Ryan A Ray on behalf of Cardinal Health, Inc. (Ray, Ryan) |
Filing 10 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Endo International plc for Endo Pharmaceuticals Inc.) by Endo Pharmaceuticals Inc. (Zschiesche, Raymond) |
Filing 9 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Endo International plc for Endo Health Solutions Inc.) by Endo Health Solutions Inc. (Zschiesche, Raymond) |
Filing 8 ATTORNEY APPEARANCE by Raymond Edward Zschiesche on behalf of Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) |
Filing 7 CORPORATE DISCLOSURE STATEMENT by AmerisourceBergen Corp. (Huntsman, Susan) |
Filing 6 ATTORNEY APPEARANCE by Susan E Huntsman on behalf of AmerisourceBergen Corp. (Huntsman, Susan) |
Filing 5 ATTORNEY APPEARANCE by D Michael McBride, III on behalf of AmerisourceBergen Corp. (McBride, D) |
Filing 4 MINUTE ORDER by Court Clerk , directing Endo Health Solutions Inc., Endo Pharmaceuticals Inc., McKesson Corp., Cardinal Health, Inc. and AmerisourceBergen Corp. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) |
Filing 3 MINUTE ORDER by Court Clerk , : Pursuant to Local Rule 81.2, the removing party(ies) shall file a Status Report on Removed Action within five (5) days of the filing of the notice of removal in the U.S. District Court. The form is available on the Court's website. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) |
Filing 2 NOTICE of Removal with Jury Demand from District Court of Tulsa County, case number CJ-2019-00063 (paid $400 filing fee; receipt number 1085-2008388) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (With attachments) (Zschiesche, Raymond) |
Filing 1 CIVIL COVER SHEET by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) |
PETITION/COMPLAINT with Jury Demand filed in State Court against All Defendants by City of Broken Arrow (jln, Dpty Clk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Oklahoma Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.